Enrollment Open in Second Phase 3 Trial of Higher TNX-102 SL Dose for Managing FM
News
The second Phase 3 clinical trial examining a higher dose of TNX-102 SL (sublingual cyclobenzaprine), Tonix Pharmaceuticals‘ bedtime treatment for managing fibromyalgia, is enrolling participants. The RALLY trial (NCT04508621) is ... Read more